Proatherogenic immune responses are regulated by the PD-1/PD-L pathway in mice

Journal of Clinical Investigation

Volumn 117, Issue 10, 2007, Pages 2974-2982

  Gotsman, Israel ^a   Grabie, Nir ^a   Dacosta, Rosa ^a   Sukhova, Galina ^a   Sharpe, Arlene ^a   Lichtman, Andrew H ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; ONCOPROTEIN; PROGRAMMED DEATH LIGAND1; PROGRAMMED DEATH LIGAND2; PROTEIN PROGRAMMED DEATH; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA; APOPTOSIS; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DENDRITIC CELL; DOWN REGULATION; HYPERCHOLESTEROLEMIA; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; INFLAMMATION; LYMPHADENOPATHY; LYMPHOCYTE ACTIVATION; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE;

ANIMALS; ANTIGEN-PRESENTING CELLS; ANTIGENS, CD80; ANTIGENS, SURFACE; AORTA; APOPTOSIS REGULATORY PROTEINS; ATHEROSCLEROSIS; CHOLESTEROL; CYTOKINES; HYPERCHOLESTEROLEMIA; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; MICE; MICE, KNOCKOUT; PEPTIDES; PHENOTYPE; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 34948904394     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI31344     Document Type: Article

References (45)

1. Hansson, G.K. 2001. Immune mechanisms in atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 21:1876-1890.
2. Zhou, X., Robertson, A.K., Rudling, M., Parini, P., and Hansson, G.K. 2005. Lesion development and response to immunization reveal a complex role for CD4 in atherosclerosis. Circ. Res. 96:427-434.
3. Zhou, X., Robertson, A.K., Hjerpe, C., and Hansson, G.K. 2006. Adoptive transfer of CD4+ T cells reactive to modified low-density lipoprotein aggravates atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 26:864-870.
4. Wick, G., Knoflach, M., and Xu, Q. 2004. Autoimmune and inflammatory mechanisms in atherosclerosis. Annu. Rev. Immunol. 22:361-403.
5. Hansson, G.K., and Libby, P. 2006. The immune response in atherosclerosis: a double-edged sword. Nat. Rev. Immunol. 6:508-519.
6. Gupta, S., et al. 1997. IFN-γ potentiates atherosclerosis in ApoE knock-out mice. J. Clin. Invest. 99:2752-2761.
7. Buono, C., et al. 2003. Influence of interferon-gamma on the extent and phenotype of diet-induced atherosclerosis in the LDLR-deficient mouse. Arterioscler. Thromb. Vasc. Biol. 23:454-460.
8. Sharpe, A.H., and Freeman, G.J. 2002. The B7-CD28 superfamily. Nat. Rev. Immunol. 2:116-126.
9. Greenwald, R.J., Freeman, G.J., and Sharpe, A.H. 2005. The B7 family revisited. Annu. Rev. Immunol. 23:515-548.
10. Keir, M.E., Latchman, Y.E., Freeman, G.J., and Sharpe, A.H. 2005. Programmed death-1 (PD-1): PD-ligand 1 interactions inhibit TCR-mediated positive selection of thymocytes. J. Immunol. 175:7372-7379.
11. Latchman, Y., et al. 2001. PD-L2 is a second ligand for PD-1 and inhibits T cell activation. Nat. Immunol. 2:261-268.
12. Freeman, G.J., et al. 2000. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J. Exp. Med. 192:1027-1034.
13. Cai, G., et al. 2004. PD-1 ligands, negative regulators for activation of naive, memory, and recently activated human CD4+ T cells. Cell. Immunol. 230:89-98.
14. Kanai, T., et al. 2003. Blockade of B7-H1 suppresses the development of chronic intestinal inflammation. J. Immunol. 171:4156-4163.
15. Buono, C., et al. 2004. B7-1/B7-2 co-stimulation regulates plaque antigen-specific T cell responses and atherogenesis in LDLR-deficient mice. Circulation. 109:2009-2015.
16. Ait-Oufella, H., et al. 2006. Natural regulatory T cells control the development of atherosclerosis in mice. Nat. Med. 12:178-180.
17. Gotsman, I., et al. 2006. Impaired regulatory T-Cell response and enhanced atherosclerosis in the absence of inducible costimulatory molecule. Circulation. 114:2047-2055.
18. Latchman, Y.E., et al. 2004. PD-L1-deficient mice show that PD-L1 on T cells, antigen-presenting cells, and host tissues negatively regulates T cells. Proc. Natl. Acad. Sci. U. S. A. 101:10691-10696.
19. Keir, M.E., et al. 2006. Tissue expression of PD-L1 mediates peripheral T cell tolerance. J. Exp. Med. 203:883-895.
20. Rodig, N., et al. 2003. Endothelial expression of PD-L1 and PD-L2 down-regulates CD8+ T cell activation and cytolysis. Eur. J. Immunol. 33:3117-3126.
21. Liang, S.C., et al. 2003. Regulation of PD-1, PD-L1, and PD-L2 expression during normal and autoimmune responses. Eur. J. Immunol. 33:2706-2716.
22. Li, A.C., et al. 2004. Differential inhibition of macrophage foam-cell formation and atherosclerosis in mice by PPARα, β/δ, and γ. J. Clin. Invest. 114:1564-1576. doi:10.1172/JCI200418730.
23. Li, M., et al. 2001. Cell-associated ovalbumin is cross-presented much more efficiently than soluble ovalbumin in vivo. J. Immunol. 166:6099-6103.
24. Leventhal, A.R., Leslie, C.C., and Tabas, I. 2004. Suppression of macrophage eicosanoid synthesis by atherogenic lipoproteins is profoundly affected by cholesterol-fatty acyl esterification and the Niemann-Pick C pathway of lipid trafficking. J. Biol. Chem. 279:8084-8092.
25. Angeli, V., et al. 2004. Dyslipidemia associated with atherosclerotic disease systemically alters dendritic cell mobilization. Immunity. 21:561-574.
26. Bobryshev, Y.V. 2005. Dendritic cells in atherosclerosis: current status of the problem and clinical relevance. Eur. Heart J. 26:1700-1704.
27. Koga, N., et al. 2004. Blockade of the interaction between PD-1 and PD-L1 accelerates graft arterial disease in cardiac allografts. Arterioscler. Thromb. Vasc. Biol. 24:2057-2062.
28. Liang, S.C., et al. 2006. PD-L1 and PD-L2 have distinct roles in regulating host immunity to cutaneous leishmaniasis. Eur. J. Immunol. 36:58-64.
29. Zhu, B., et al. 2006. Differential role of programmed death-ligand 1 and programmed death-ligand 2 in regulating the susceptibility and chronic progression of experimental autoimmune encephalomyelitis. J. Immunol. 176:3480-3489.
30. Salama, A.D., et al. 2003. Critical role of the programmed death-1 (PD-1) pathway in regulation of experimental autoimmune encephalomyelitis. J. Exp. Med. 198:71-78.
31. Ansari, M.J., et al. 2003. The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice. J. Exp. Med. 198:63-69.
32. Ding, Q., et al. 2006. B7H1-Ig fusion protein activates the CD4+ IFN-gamma receptor+ type 1 T regulatory subset through IFN-gamma-secreting Th1 cells. J. Immunol. 177:3606-3614.
33. Eppihimer, M.J., et al. 2002. Expression and regulation of the PD-L1 immunoinhibitory molecule on microvascular endothelial cells. Microcirculation. 9:133-145.
34. Schoop, R., et al. 2004. Suppressed T-cell activation by IFN-gamma-induced expression of PD-L1 on renal tubular epithelial cells. Nephrol. Dial. Transplant. 19:2713-2720.
35. Llodra, J., et al. 2004. Emigration of monocyte-derived cells from atherosclerotic lesions characterizes regressive, but not progressive, plaques. Proc. Natl. Acad. Sci. U. S. A. 101:11779-11784.
36. Ludewig, B., et al. 2001. Hypercholesterolemia exacerbates virus-induced immunopathologic liver disease via suppression of antiviral cytotoxic T cell responses. J. Immunol. 166:3369-3376.
37. Robertson, A.K., and Hansson, G.K. 2006. T cells in atherogenesis: for better or for worse? Arterioscler. Thromb. Vasc. Biol. 26:2421-2432.
38. Trautmann, L., et al. 2006. Upregulation of PD-1 expression on HIV-specific CD8(+) T cells leads to reversible immune dysfunction. Nat. Med. 12:1198-1202.
39. Freeman, G.J., Wherry, E.J., Ahmed, R., and Sharpe, A.H. 2006. Reinvigorating exhausted HIV-specific T cells via PD-1-PD-1 ligand blockade. J. Exp. Med. 203:2223-2227.
40. Day, C.L., et al. 2006. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature. 443:350-354.
41. Buono, C., et al. 2005. T-bet deficiency reduces atherosclerosis and alters plaque antigen-specific immune responses. Proc. Natl. Acad. Sci. U. S. A. 102:1596-1601.
42. Paigen, B., Morrow, A., Holmes, P.A., Mitchell, D., and Williams, R.A. 1987. Quantitative assessment of atherosclerotic lesions in mice. Atherosclerosis. 68:231-240.
43. Grabie, N., et al. 2003. IL-12 is required for differentiation of pathogenic CD8+ T cell effectors that cause myocarditis. J. Clin. Invest. 111:671-680. doi:10.1172/JCI200316867.
44. Usui, S., Hara, Y., Hosaki, S., and Okazaki, M. 2002. A new on-line dual enzymatic method for simultaneous quantification of cholesterol and triglycerides in lipoproteins by HPLC. J. Lipid Res. 43:805-814.
45. Dong, H., Zhu, G., Tamada, K., and Chen, L. 1999. B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion. Nat. Med. 5:1365-1369.